DNMT1 and Burkitt lymphoma: In summary, the genomic location analysis together with expression profiling indicates that MYC directly binds to DNMT1 and DNMT3B in T-ALL and Burkitt’s lymphoma, thereby establishing both DNMTs as direct transcriptional targets of the MYC oncoprotein.